Spots Global Cancer Trial Database for refractory and relapsed malignant brain tumors
Every month we try and update this database with for refractory and relapsed malignant brain tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | NCT00418327 | Malignant Brain... Brain Stem Glio... | Tarceva (Erloti... | 1 Year - 21 Years | Gustave Roussy, Cancer Campus, Grand Paris |